Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults with Emotional Distress
针对患有情绪困扰的成年人的经过 PST 培训的语音人工智能咨询师 (SPEAC) 的研究
基本信息
- 批准号:10611145
- 负责人:
- 金额:$ 108.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-03 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAffectAmygdaloid structureAnxietyAreaArtificial IntelligenceAttitudeBrainClinicalCognitionCognitiveComputer softwareDevelopmentDevicesDorsalDoseEmotionalEmotionsEngineeringEnrollmentEvaluationFaceFocus GroupsFunctional Magnetic Resonance ImagingFunctional disorderFutureGeneralized Anxiety DisorderHealthHealth PromotionHealth ResourcesHumanImage AnalysisIntelligenceLateralLengthMachine LearningMeasurementMeasuresMediatingMental DepressionMental HealthMental Health ServicesMoodsNamesNeurosciencesOutcomeParticipantPatient Outcomes AssessmentsPatient Self-ReportPatientsPersonal SatisfactionPersonsPhasePrefrontal CortexProblem SolvingProceduresProcess MeasureProductivityProfessional counselorProtocols documentationPsychotherapyPublic HealthQuality of lifeQuestionnairesRandomizedRandomized Clinical TrialsResearchSecureSpecific qualifier valueStressSurveysSymptomsTechniquesTestingTherapeuticTimeTrainingTranslatingTreatment EfficacyUnited States National Institutes of HealthVoiceVoice TrainingWaiting Listsactive controlactive methodanxiety symptomsarmbasebehavioral health interventionclinical decision supportcognitive controlconnected carecopingcostdepressive symptomsdigital medicinedisabilityefficacy testingemotional distressexperiencefollow up assessmentformative assessmentimprovedinnovationinsightintelligent agentiterative designknowledge basemeetingsneural circuitneuromechanismnew technologynovelpilot testproblem solving therapyprototyperecruitrelating to nervous systemsocial stigmatargeted treatmenttheoriestreatment armtreatment optimizationusabilityuser centered designvirtualvirtual health
项目摘要
PROJECT SUMMARY
BACKGROUND: Depression and anxiety are the leading causes of disability and lost productivity, and are
often underdiagnosed and undertreated owing to access, cost, and stigma barriers. Novel and scalable
psychotherapies are urgently needed. Advances in artificial intelligence (AI) offer a transformative opportunity
to develop intelligent voice assistants as virtual health agents accessible on personal devices. Meanwhile,
major advances in human neuroscience have fueled a paradigm shift to study brain mechanisms underlying
behavioral health interventions. OBJECTIVES: Leveraging our collaborative team’s transdisciplinary expertise
in these emerging areas, we will develop and rigorously test a novel voice-enabled, AI virtual agent named
Lumen, trained on Problem Solving Therapy (PST), for patients with moderate, untreated depressive and/or
anxiety symptoms. We will investigate the effect of Lumen on engagement of a priori neural targets—amygdala
for emotional reactivity and dorsal lateral prefrontal cortex (DLPFC) for cognitive control—as putative
mechanisms. DESIGN/ METHODS: The project has 2 phases. In the R61 phase (years 1-2), we will further
develop Lumen building on the current prototype and conduct iterative user-centered design evaluations that
include focus groups, scenario-based clinician evaluations, and a formative user study with 20 participants. We
will pilot test Lumen in a 2-arm randomized clinical trial (RCT, Study 1), with 60 participants with depression
and/or anxiety randomized in a 2:1 ratio to receive PST with Lumen (n=40) on a secure study iPad or be on a
waitlist (n=20). At weeks 0 and 14, participants will complete functional magnetic resonance imaging (fMRI) to
assess neural target engagement as well as validated surveys of patient-reported outcomes (e.g., depressive
and anxiety symptoms, functioning, quality of life). In addition, they will complete naturalistic end-of-day
assessments of mood, stress, appraisal and coping for 7 days every 2 weeks. If the Go milestone criteria are
met, the R33 phase (years 3-5) will include a 3-arm RCT (Study 2) with 200 new participants randomized in a
2:1:1 ratio to 1 of 3 arms: Lumen (n=100), waitlist control (n=50), and in-person PST as active control (n=50).
Participants will complete baseline and follow-up assessments using a refined measurement protocol based on
Study 1. SPECIFIC AIMS: R61 aims are to (1) establish the functionality, usability, and treatment fidelity of
Lumen; and (2) demonstrate feasibility, acceptability, and neural target engagement according to pre-specified
Go milestone criteria. R33 aims are to (1) confirm neural target engagement by a superiority test (primary)
comparing the Lumen and waitlist control arms and a noninferiority test (secondary) comparing the Lumen and
in-person PST arms; and (2) examine the relationships of target engagement to outcomes. The results will
provide the basis for future confirmatory efficacy testing of Lumen. IMPACT: This project’s public health impact
lies in that a mechanistically tested, PST-trained AI agent could bring proven psychotherapy to people with
depression/anxiety who do not seek professional help or who desire more personalized, connected care.
项目摘要
背景:抑郁和焦虑是残疾和生产力下降的主要原因,
由于获取、费用和耻辱障碍,往往诊断不足和治疗不足。新颖且可扩展
迫切需要心理治疗。人工智能(AI)的进步提供了一个变革性的机会
开发智能语音助手作为个人设备上可访问的虚拟健康代理。同时,
人类神经科学的重大进展推动了研究大脑机制的范式转变,
行为健康干预。优势:利用我们合作团队的跨学科专业知识
在这些新兴领域,我们将开发并严格测试一种新型的语音智能虚拟代理,
Lumen,接受过问题解决疗法(PST)的培训,适用于中度、未经治疗的抑郁症和/或
焦虑症状我们将研究Lumen对先验神经靶点-杏仁核参与的影响
情绪反应和背外侧前额叶皮层(DLPFC)的认知控制-作为假定
机制等设计/方法:分2个阶段进行。在R61阶段(1 - 2年),我们将进一步
在当前原型的基础上开发Lumen,并进行以用户为中心的迭代设计评估,
包括焦点小组、基于ECOMO的临床医生评估和有20名参与者的形成性用户研究。我们
我将在一项2组随机临床试验(RCT,研究1)中对Lumen进行初步测试,有60名抑郁症患者参与
和/或焦虑以2:1的比例随机分配,在安全研究iPad上接受PST with Lumen(n = 40),或在
waitlist(n = 20)。在第0周和第14周,参与者将完成功能性磁共振成像(fMRI),
评估神经目标接合以及患者报告结果的有效调查(例如,抑郁
和焦虑症状、功能、生活质量)。此外,他们将完成自然主义的结束日
每2周进行7天的情绪、压力、评价和应对评估。如果Go里程碑标准为
满足,R33阶段(第3 - 5年)将包括一项3组RCT(研究2),其中200名新受试者随机分配至
3个组中的1个组的比例为2:1:1:Lumen(n = 100)、等待列表对照组(n = 50)和作为主动对照组的亲自PST(n = 50)。
参与者将使用基于以下内容的精确测量方案完成基线和随访评估:
研究1.具体目标:R61的目标是(1)建立
管腔;和(2)根据预先规定,证明可行性、可接受性和神经靶点接合
执行里程碑标准。R33的目的是(1)通过优效性检验(主要)确认神经目标接合
比较管腔对照组和等待列表对照组,以及比较管腔对照组和等待列表对照组的非劣效性检验(次要)。
亲自PST武器;(2)检查目标参与结果的关系。结果将
为将来Lumen的确认有效性测试提供基础。影响:该项目的公共卫生影响
一个经过机械测试、经过PST训练的人工智能代理人可以为患有以下疾病的人带来经过验证的心理治疗:
抑郁症/焦虑症患者不寻求专业帮助或希望获得更个性化、更有联系的护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Olusola A. Ajilore其他文献
When ChatGPT Met RDoC: Leveraging Artificial Intelligence to Bridge the Gap Between Data and Prognosis
当ChatGPT遇上研究领域标准(RDoC):利用人工智能弥合数据与预后之间的差距
- DOI:
10.1016/j.biopsych.2024.09.020 - 发表时间:
2024-12-15 - 期刊:
- 影响因子:9.000
- 作者:
Olusola A. Ajilore - 通讯作者:
Olusola A. Ajilore
Altered Effective Connectivity During Threat Anticipation in Individuals With Alcohol Use Disorder
酒精使用障碍患者在威胁预期期间的有效连接改变
- DOI:
10.1016/j.bpsc.2024.07.023 - 发表时间:
2025-02-01 - 期刊:
- 影响因子:4.800
- 作者:
Milena Radoman;K. Luan Phan;Olusola A. Ajilore;Stephanie M. Gorka - 通讯作者:
Stephanie M. Gorka
Olusola A. Ajilore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Olusola A. Ajilore', 18)}}的其他基金
Unobtrusive Monitoring of Affective Symptoms and Cognition using Keyboard Dynamics
使用键盘动力学对情感症状和认知进行不引人注目的监测
- 批准号:
10406131 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
Unobtrusive Monitoring of Affective Symptoms and Cognition using Keyboard Dynamics
使用键盘动力学对情感症状和认知进行不引人注目的监测
- 批准号:
10542659 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
3/3-Recurrence markers, cognitive burden and neurobiological homeostasis in late-life depression
3/3-晚年抑郁症的复发标记、认知负担和神经生物学稳态
- 批准号:
10532208 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults with Emotional Distress
针对患有情绪困扰的成年人的经过 PST 培训的语音人工智能咨询师 (SPEAC) 的研究
- 批准号:
10671735 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
Unobtrusive Monitoring of Affective Symptoms and Cognition using Keyboard Dynamics
使用键盘动力学对情感症状和认知进行不引人注目的监测
- 批准号:
10320061 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
Unobtrusive Monitoring of Affective Symptoms and Cognition using Keyboard Dynamics
使用键盘动力学对情感症状和认知进行不引人注目的监测
- 批准号:
10115131 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
Unobtrusive Monitoring of Affective Symptoms and Cognition using Keyboard Dynamics
使用键盘动力学对情感症状和认知进行不引人注目的监测
- 批准号:
9912649 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults with Emotional Distress
针对患有情绪困扰的成年人的经过 PST 培训的语音人工智能咨询师 (SPEAC) 的研究
- 批准号:
10031359 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
3/3-Recurrence markers, cognitive burden and neurobiological homeostasis in late-life depression
3/3-晚年抑郁症的复发标记、认知负担和神经生物学稳态
- 批准号:
10078636 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
3/3-Recurrence markers, cognitive burden and neurobiological homeostasis in late-life depression
3/3-晚年抑郁症的复发标记、认知负担和神经生物学稳态
- 批准号:
10304162 - 财政年份:2020
- 资助金额:
$ 108.87万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 108.87万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 108.87万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 108.87万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 108.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 108.87万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 108.87万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 108.87万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 108.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 108.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 108.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)